
Keywords: هرا; Breast cancer; Young age; Triple-negative subtype; BRCA mutation; ACOSOG; American college of surgeons oncology group; BCSS; breast cancer-specific survival; BCT; breast-conserving therapy; CI; confidence interval; CBC; contralateral breast cancer; CPM; c